Nanobiotix FY 2023 GAAP EPS $(1.17) Beats $(1.66) Estimate, Sales $39.323M Beat $13.680M Estimate
Nanobiotix FY 2023 GAAP EPS $(1.17) Beats $(1.66) Estimate, Sales $39.323M Beat $13.680M Estimate
Nanobiotix2023财年GAAP每股收益美元（1.17美元）超过预期（1.66美元），销售额39323万美元超过预期的136.8亿美元
Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.66) by 29.52 percent. This is a 32.37 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $39.323 million which beat the analyst consensus estimate of $13.680 million by 187.45 percent. This is a 681.30 percent increase over sales of $5.033 million the same period last year.
Nanobiotix（纳斯达克股票代码：NBTX）公布的季度亏损为每股1.17美元，比分析师普遍预期的1.66美元（1.66美元）高出29.52％。这比去年同期每股亏损1.73美元（1.73美元）增长了32.37％。该公司公布的季度销售额为3932.3万美元，比分析师普遍预期的136.8亿美元高出187.45％。这比去年同期的503.3万美元的销售额增长了681.30％。